More Information on 'Winnoz Technology Inc'

About Winnoz Technology Inc
Winnoz® is a biotech company focused on the Point of Care Testing platform technology (POCT). Our vision is to be the family health steward of every customer. With the POCT platform from blood collection, detection and big data analysis, we enable more contribution for human health management for anyone, anywhere. We first launched the WinGene genetic testing service by offering risk report with genetic testing to better assist customers in managing health and well-being. In 2019, our patented technology Haiim®, a unique blood collection device, obtained Taiwan FDA Class I Medical Device and got CE certified in 2020. Now, we collaborate with many worldwide distributors for global expansion and aim for US FDA cleared by 2021. We also developed eGGi molecular detection system, a compact and robust instrument, which is based on isothermal DNA/RNA amplification method that can be used in airports, sport venues, pharmacies and workplaces.